REVA raises A$85 million through IPO

Dec 21 2010NewsGuard 100/100 Score

REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Initial Public Offering (the Offer) has closed and that the Company has raised $A85,000,003.

The Lead Manager to the Offer was boutique Sydney based Investment Bank, Inteq Limited. Southern Cross Securities Limited and Taylor Collison Limited acted as Lead Brokers.

The Offer was conducted by way of a US Prospectus filed with the United States Securities & Exchange Commission and an Australian Prospectus and Supplementary filed with the Australian Securities & Investments Commission.

REVA issued 7,727,273 new shares of common stock representing 77,272,730 CHESS Depositary Interests, or CDIs, priced at A$1.10 per CDI. The ratio of CDIs to common stock is 10:1.

REVA is also pleased to confirm that the Australian Securities Exchange (ASX) has granted approval, subject to certain conditions, for REVA to list on the ASX and have its CDIs start trading from 11.30am on Thursday 23 December 2010 (AEDT). The ASX stock code is "RVA".

REVA Medical, Inc.

Posted in:

Tags: ,

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback